The aim of this study is to examine the relationship between plasma putative biomarkers for
Alzheimer's disease (i.e. Ab40 amyloid and total Ab42 amyloid, free, bound, free/bound,
truncated, sAPPα) and :
- the risk of conversion of individuals with Mild Cognitive Impairment (MCI) into
Alzheimer's disease (AD),
- the Alzheimer's disease progression rate.